findmyKOL
Clinical trialNCT00000870CompletedPhase 2Interventional

A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment200HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Alabama Therapeutics Crs

    Birmingham, Alabama, United States

  • Usc Crs

    Los Angeles, California, United States

  • Stanford Crs

    Palo Alto, California, United States

  • Harbor-Ucla Med. Ctr. Crs

    Torrance, California, United States

  • University of Colorado Hospital Crs

    Aurora, Colorado, United States

  • Univ. of Hawaii at Manoa, Leahi Hosp.

    Honolulu, Hawaii, United States

  • Univ. of Iowa Healthcare, Div. of Infectious Diseases

    Iowa City, Iowa, United States

  • Tulane Univ. A1701 Crs

    New Orleans, Louisiana, United States

  • Beth Israel Deaconess - East Campus A0102 Crs

    Boston, Massachusetts, United States

  • St. Louis Connectcare, Infectious Diseases Clinic

    St Louis, Missouri, United States

  • Beth Israel Med. Ctr. (mt. Sinai)

    New York, New York, United States

  • Mt. Sinai Med. Ctr. (n.Y.) A1801 Crs

    New York, New York, United States

  • Ny Univ. Hiv/aids Crs

    New York, New York, United States

  • Weill Med. College of Cornell Univ., the Cornell Ctu

    New York, New York, United States

  • Unc Aids Crs

    Chapel Hill, North Carolina, United States

  • Duke Univ. Med. Ctr. Adult Crs

    Durham, North Carolina, United States

  • Case Crs

    Cleveland, Ohio, United States

  • the Ohio State Univ. Aids Crs

    Columbus, Ohio, United States

  • Univ. of Texas Medical Branch, Actu

    Galveston, Texas, United States

  • University of Washington Aids Crs

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
Primary completion
Completion
31 Mar 2007
Last update posted
21 May 2012
Registered enrollment
200
Registry id
NCT00000870

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.